Pradaxa has Woefully Inadequate Warnings and Precautions About Serious Bleeding Risks

Despite the serious risks associated with daily usage of Pradaxa, Boehringer Ingelheim, the drugs creator, fails to adequately warn patients of the dangers involved. Evidence of this claim is demonstrated when reviewing a study issued by the Institute for Safe Medication Practices, which reported that out of the 272,119 prescriptions issued for Pradaxa in the […]

Pradaxa Side Effects Outweigh Any Supposed Benefit In Terms of Patient Safety

While Pradaxa, a recently developed oral anticoagulant intended to combat the risk of stroke in patients with atrial fibrillation (AF), was created with an eye to sidestepping many of the limitations associated with Warfarin, Pradaxa’s main competitor, new and potentially more dangerous hazards have arisen with respect to its prescription. Boehringer Ingelheim, the international pharmaceutical […]

J&J Irresponsibly Fails to Recall Vaginal Mesh Implants

In response to an increase in the amount of reported injuries and lawsuits resulting from surgical mesh implants, Johnson & Johnson has decided to stop selling the product used to treat women’s health problems. The company expressed its desire to do so in a letter sent to judges in New Jersey and West Virginia who […]

J&J Irresponsibly Fails to Recall Vaginal Mesh Implants

In response to an increase in the amount of reported injuries and lawsuits resulting from surgical mesh implants, Johnson & Johnson has decided to stop selling the product used to treat women’s health problems. The company expressed its desire to do so in a letter sent to judges in New Jersey and West Virginia who […]

Canadian Study Finds an 83% Increased Risk of Bladder Cancer in Actos Users

In a new Canadian study recently published in the British Medical Journal on the side effects of Actos, it was reported that people being treated for type 2 diabetes with Takeda Pharmaceutical’s drug Actos may be putting themselves at risk for bladder cancer. Lead researcher Laurent Azoulay and her team colleted data on 115,727 patients […]

J&J Subsidiary Ethicon To Stop Selling Dangerous Vaginal Mesh Products

Johnson & Johnson subsidiary Ethicon announced today that it will cease marketing most of its vaginal mesh products. This announcement was made in two letters sent to the judges who are coordinating the Federal Multi-District Transvaginal Mesh Litigation in West Virginia, and in the coordinated New Jersey State Court Litigation. The company will be informing […]

J&J Subsidiary Ethicon To Stop Selling Dangerous Vaginal Mesh Products

Johnson & Johnson subsidiary Ethicon announced today that it will cease marketing most of its vaginal mesh products. This announcement was made in two letters sent to the judges who are coordinating the Federal Multi-District Transvaginal Mesh Litigation in West Virginia, and in the coordinated New Jersey State Court Litigation. The company will be informing […]